Abstract
THE absence of a measurable pharmacological action of Staphylococcus enterotoxin in small laboratory animals limits investigation of the mode of action of this toxin. In view of published work in which drug interactions have been used to examine mechanisms of action1,2 we undertook an investigation of the toxicity of combined treatments of Staphylococcus enterotoxin and methyl-dopa in mice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rossi, G. V., J. Pharmaceut. Sci., 53, 819 (1963).
Sugiyama, H., Bergdoll, M. S., and Dack, G. M., Proc. Soc. Exp. Biol. Med., 97, 900 (1958).
Reed, L. J., and Muench, H., Amer. J. Hygiene, 27, 493 (1938).
Hess, S., Connamacher, R. H., Ozaki, M., and Udenfriend, S., J. Pharmacol., and Exp, Therap., 134, 129 (1961).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LAL, H., BLAIR, W., EHRLICH, R. et al. Combined Toxicity of Staphylococcal Enterotoxin and α-Methyl-3,4-dihydroxy-1-phenylalanine (Methyl-dopa). Nature 202, 1226 (1964). https://doi.org/10.1038/2021226a0
Issue date:
DOI: https://doi.org/10.1038/2021226a0
